Google Cloud Launches Artificial Intelligence Tools to Accelerate Drug Discovery and Precision Medic

On May 16, Google Cloud announced two new artificial intelligence life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical companies and public sector organizations. One, called Target and Lead Identification Suite, is now available globally to help researchers better identify the function of amino acids and predict the structure of proteins; the other, called Multiomics Suite, accelerates the discovery and interpretation of genomic data to help companies design precise therapies.